Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

7 clinical trials · 7 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

RECRUITINGPhase 2NCT06832774

Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation...

At present, there is still controversy over the treatment of metastatic hormone sensitive prostate cancer (mHSPC). Major guidelines and consensus suggest that novel hormone...

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling: 1921 location
Prostate Cancer Metastatic Disease
RECRUITINGNCT06592989

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

The incidence rate of pancreatic neuroendocrine neoplasms (pNENs) is increasing year by year. According to the statistical results of the SEER (Surveillance, Epidemiology, and End...

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling: 201 location
Pancreatic Neuroendocrine NeoplasmSorafenibGefitinib
RECRUITINGNCT07007832

Bile Omics for Diagnosing Indeterminate Biliary Strictures

The diagnosis of malignant biliary strictures remains a challenging aspect of biliary endoscopy. Molecular biological testing techniques based on bile have been reported to...

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling: 2601 location
CholangiocarcinomaGallbladder Cancer and Extrahepatic CholangiocarcinomaPancreatic Cancer+2
RECRUITINGEarly Phase 1NCT06652243

Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma

This is a single-arm, open-label study of safety, tolerability, and anti-cancer activity of SN301A (an off-the-shelf CAR NK cell therapy) in patients with glypican-3...

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling: 121 location
Hepatocellular Carcinoma (HCC)
RECRUITINGEarly Phase 1NCT07053358

Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients

The goal of this study is to evaluate the safety and efficacy of LX111 treatment of nAMD. This study will enroll subjects aged ≥ 50 vears old to receive a single unilateral...

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling: 101 location
Neovascular Age-related Macular Degeneration
RECRUITINGNCT05465252

Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression

This randomized, double-blind, placebo-controlled study aims to evaluate the effect of krill oil supplementation in patients with dry age-related macular degeneration (AMD)....

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling: 241 location
Age-Related Macular Degeneration
RECRUITINGPhase 1NCT06936787

An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa

This is an investigator-initiated, prospective, single-center, open-label, single ascending dose clinical study. The study aims to evaluate the safety, tolerability, and potential...

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling: 211 location
Retinitis Pigmentosa